GlaxoSmithKline Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 7,916.200 million compared to INR 8,035.300 million a year ago. Net income was INR 1,380.700 million compared to INR 1,468.100 million a year ago. For the full year, total revenue was INR 33,033.900 million compared to INR 32,304.400 million a year ago. Net income was INR 932.000 million compared to INR 4,453.900 million a year ago.